Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine or Quetiapine Added to Mood Stabilizers in Bipolar Depression
2009-011253-40Phase 3Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of paroxetine and quetiapine in bipolar disorder (BD) (2 arms), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Change in depressive symptoms (HAM-D mean reduction), Response rate on HAM-D and 2 more. Started Apr 2009; status: active.
02
Drugs
paroxetinequetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2009-011253-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011253-40.